GLP-1 use tied to reductions in substance use and harmful outcomes (IMAGE)
Caption
A study by WashU Medicine researchers finds GLP-1 use is associated with seven fewer new cases of substance use disorder and 12 fewer harmful events related to substance use among every 1,000 people taking a GLP-1 for diabetes, compared to those taking a non-GLP-1 medication.
Credit
Sara Moser / WashU Medicine
Usage Restrictions
This image is to be used in accordance with the mission, policies and guidelines of Washington University in St. Louis. Visit https://wustl.edu/about/compliance-policies/media-policies/multimedia-use/ for more information.
License
Original content